Загрузка...
TSC1 promotes iNKT cell anergy and inhibits iNKT cell-mediated anti-tumor immunity
Development of effective immune therapies for cancer patients requires better understanding of hurdles that prevent the generation of effective anti-tumor immune responses. Administration of α-galactosylceramide (α-GalCer) in animals enhances anti-tumor immunity via activation of the invariant natur...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965184/ https://ncbi.nlm.nih.gov/pubmed/24532578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1302076 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|